Daniel Moore Net Worth

The estimated Net Worth of Daniel Jeffrey Moore is at least $8.96 Milhão dollars as of 3 June 2024. Mr. Moore owns over 56,623 units of LivaNova PLC stock worth over $3,993,250 and over the last 9 years he sold LIVN stock worth over $4,594,505. In addition, he makes $369,908 as Independent Chairman of the Board at LivaNova PLC.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Moore LIVN stock SEC Form 4 insiders trading

Daniel has made over 57 trades of the LivaNova PLC stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 56,623 units of LIVN stock worth $3,249,594 on 3 June 2024.

The largest trade he's ever made was buying 96,358 units of LivaNova PLC stock on 10 May 2022 worth over $249,567. On average, Daniel trades about 3,242 units every 43 days since 2015. As of 3 June 2024 he still owns at least 84,157 units of LivaNova PLC stock.

You can see the complete history of Mr. Moore stock trades at the bottom of the page.

Daniel Moore biography

Daniel Jeffrey Moore is Independent Chairman of the Board of the Company. Daniel Moore is Chairman of the Board of the Company and, over the past five years, has served primarily as a private investor. Mr. Moore served as President and CEO and a member of the board of Cyberonics, Inc., a medical device company with core expertise in neuromodulation, from 2007 to 2015 when Cyberonics merged with Sorin S.p.a. to form the Company. Mr. Moore joined Cyberonics after 18 years with Boston Scientific where he was President of InterContinental as well as having roles in general management, sales and marketing earlier in his career. Mr. Moore has a B.A. from Harvard College and an Executive M.B.A. from Boston University.

What is the salary of Daniel Moore?

As the Independent Chairman of the Board of LivaNova PLC, the total compensation of Daniel Moore at LivaNova PLC is $369,908. There are 7 executives at LivaNova PLC getting paid more, with Damien McDonald having the highest compensation of $7,131,930.

How old is Daniel Moore?

Daniel Moore is 59, he's been the Independent Chairman of the Board of LivaNova PLC since 2015. There are 8 older and 13 younger executives at LivaNova PLC. The oldest executive at LivaNova PLC is Arthur Rosenthal, 73, who is the Independent Director.

What's Daniel Moore's mailing address?

Daniel's mailing address filed with the SEC is 20 EASTBOURNE TERRACE, , LONDON, X0, W2 6LG.

Insiders trading at LivaNova PLC

Over the last 9 years, insiders at LivaNova PLC have traded over $79,802,010 worth of LivaNova PLC stock and bought 4,000 units worth $268,530 . The most active insiders traders include William A Kozy, Two S.C.A.Tower 6 S. A R.L...., ePeter M Wilver. On average, LivaNova PLC executives and independent directors trade stock every 10 days with the average trade being worth of $315,922. The most recent stock trade was executed by Peter M Wilver on 15 June 2024, trading 2,680 units of LIVN stock currently worth $127,166.

What does LivaNova PLC do?

livanova plc is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.at livanova, we understand the importance of bringing both clinical and economic value to our customers. we are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. livanova is listed on the nasdaq stock exchange under the ticker symbol “livn.” livanova has approximately 3,000 employees worldwide. we are headquartered in london (uk) and maintain a presence in more than 100 countries. livanova is a worldwide leader in advanced circulatory support, cardiopulmonary and neuromodulation, dedicated to creating meaningful products and therapies that transform lives each and every day.

Complete history of Mr. Moore stock trades at LivaNova PLC e ViewRay

LivaNova PLC executives and stock owners

LivaNova PLC executives and other stock owners filed with the SEC include:

• Damien McDonald,
  Chief Executive Officer, Director
• Keyna Skeffington,
  Senior Vice President, General Counsel and Company Secretary
• Alistair Simpson,
  Special Advisor
• Edward Andrle,
  Special Advisor
• Damien McDonald,
  CEO & Director
• Keyna Pidcock Skeffington,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Alex Shvartsburg,
  CFO and Corp. VP of Financial Planning, Analysis & International Region
• Daniel Moore,
  Independent Chairman of the Board
• Hugh Morrison,
  Independent Director
• Alfred Novak,
  Independent Director
• Francesco Bianchi,
  Independent Director
• Arthur Rosenthal,
  Independent Director
• Andrea Saia,
  Independent Director
• Sharon O'Kane,
  Independent Director
• William Kozy,
  Independent Director
• Stacy Seng,
  Independent Director
• Marco Dolci,
  Head of Global Operations and R&D
• Roy Khoury,
  President - International, Senior Vice President - Global Strategic Marketing
• Trui Hebbelinck,
  Chief Human Resource Officer
• Alex Shvartsburg,
  Interim Chief Financial Officer
• Stephanie Bolton,
  Pres of International Region
• Paul R. Buckman,
  Pres of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement
• Dr. Bryan D. Olin Ph.D.,
  Sr. VP & Head of Product Devel. - Neuromodulation
• Trui Hebbelinck,
  Chief HR Officer
• Matthew Joseph Dodds III,
  Sr. VP of Corp. Devel.
• Deanna Wilke,
  Director of Corp. Communications
• Lullo Stefano Di,
  Pres Cardiac Rhythm Mgmt
• Michel Darnaud,
  President Cardiac Surgery
• Thad Allen Huston,
  Chief Financial Officer
• Vivid Sehgal,
  CFO
• Two S.C.A.Tower 6 S. A R.L....,
  
• Jacques Gutedel,
  President Intercontinental
• Stefano Gianotti,
  Director
• Piero Vecchi,
  VP & Controller
• Pritpal Shinmar,
  SR VP Global Market Access
• Robert Jason Richey,
  President, Neuromodulation
• Douglas John Manko,
  Chief Accounting Officer
• David S Wise,
  SR VP HR & IT
• Todd C Schermerhorn,
  Director
• Ahmet Tezel,
  Chief Innovation Officer
• Brian Sheridan,
  SR VP Genl Counsel & Secretary
• Andre Michel Ballester,
  CEO
• Demetrio Mauro,
  Chief Integration Officer
• James Christopher Barry,
  Director
• Peter M Wilver,
  Director
• Brooke Story,
  Director
• Michael Damon Hutchinson,
  Chief Legal Officer
• Stephanie Bolton,
  President, Global Epilepsy
• Vladimir Makatsaria,
  Chief Executive Officer